Thrivent Financial for Lutherans Acquires 2,947 Shares of Teleflex Incorporated (NYSE:TFX)

Thrivent Financial for Lutherans increased its stake in shares of Teleflex Incorporated (NYSE:TFX) by 20.2% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 17,567 shares of the medical technology company’s stock after acquiring an additional 2,947 shares during the quarter. Thrivent Financial for Lutherans’ holdings in Teleflex were worth $3,695,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds also recently made changes to their positions in the company. Mirae Asset Global Investments Co. Ltd. bought a new position in shares of Teleflex during the first quarter valued at about $2,467,000. Hsbc Holdings PLC grew its position in shares of Teleflex by 13.3% in the 4th quarter. Hsbc Holdings PLC now owns 83,474 shares of the medical technology company’s stock worth $20,795,000 after buying an additional 9,807 shares during the last quarter. ProShare Advisors LLC increased its stake in shares of Teleflex by 34.1% during the first quarter. ProShare Advisors LLC now owns 12,200 shares of the medical technology company’s stock valued at $2,759,000 after buying an additional 3,105 shares during the period. Wellington Management Group LLP lifted its stake in Teleflex by 2.1% in the fourth quarter. Wellington Management Group LLP now owns 2,496,566 shares of the medical technology company’s stock worth $622,494,000 after acquiring an additional 52,533 shares during the period. Finally, Tidal Investments LLC boosted its holdings in Teleflex by 214.7% in the first quarter. Tidal Investments LLC now owns 6,644 shares of the medical technology company’s stock valued at $1,503,000 after acquiring an additional 4,533 shares in the last quarter. 95.62% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, Director Stuart A. Randle sold 2,674 shares of the stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $238.93, for a total transaction of $638,898.82. Following the transaction, the director now owns 5,496 shares in the company, valued at $1,313,159.28. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Insiders own 1.43% of the company’s stock.

Teleflex Trading Up 0.8 %

NYSE TFX opened at $246.83 on Friday. The stock’s fifty day moving average price is $237.48 and its 200-day moving average price is $221.22. The company has a current ratio of 2.58, a quick ratio of 1.44 and a debt-to-equity ratio of 0.36. The stock has a market cap of $11.63 billion, a P/E ratio of 39.62, a P/E/G ratio of 2.23 and a beta of 1.16. Teleflex Incorporated has a 12 month low of $177.63 and a 12 month high of $257.85.

Teleflex (NYSE:TFX) last announced its quarterly earnings results on Thursday, August 1st. The medical technology company reported $3.42 earnings per share for the quarter, beating the consensus estimate of $3.33 by $0.09. Teleflex had a net margin of 8.76% and a return on equity of 14.51%. The company had revenue of $749.70 million during the quarter, compared to the consensus estimate of $762.98 million. During the same quarter last year, the firm earned $3.41 earnings per share. The firm’s quarterly revenue was up .9% compared to the same quarter last year. As a group, equities analysts forecast that Teleflex Incorporated will post 13.97 EPS for the current fiscal year.

Teleflex Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, September 16th. Shareholders of record on Thursday, August 15th were paid a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a yield of 0.55%. The ex-dividend date of this dividend was Thursday, August 15th. Teleflex’s dividend payout ratio is currently 21.83%.

Analysts Set New Price Targets

Several equities research analysts have recently commented on TFX shares. Truist Financial raised their target price on shares of Teleflex from $240.00 to $247.00 and gave the stock a “hold” rating in a research report on Monday, August 5th. Stephens upped their target price on Teleflex from $275.00 to $290.00 and gave the stock an “overweight” rating in a report on Friday, August 2nd. Royal Bank of Canada lifted their price target on Teleflex from $235.00 to $260.00 and gave the company an “outperform” rating in a research report on Friday, August 2nd. Finally, Piper Sandler upgraded Teleflex from a “neutral” rating to an “overweight” rating and increased their price objective for the stock from $205.00 to $245.00 in a report on Monday, July 1st. Three equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $265.57.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.